Search research articles
Contact Us
Filters
Showing results (21-30 of 43) with videos related to
Page
of 5
Sort By:
Cancers
|
November 13, 2025
SLAMF7: A Potential Target for CAR T-Cell Therapy in Multiple Myeloma
Caterina Alati, Martina Pitea, Gaetana Porto, et al.
Cancers
|
September 13, 2025
CD19 CAR-T Outcomes in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Retrospective Cohort Study from the Calabria Referral Center in Southern Italy
Daniele Caracciolo, Filippo Antonio Canale, Virginia Naso, et al.
Expert Review of Hematology
|
July 17, 2024
Optimizing maintenance therapy in acute myeloid leukemia: where do we stand in the year 2024?
Caterina Alati, Martina Pitea, Maria Caterina Mico, et al.
Cancers
|
September 27, 2025
CAR-T Cell Therapies in B-Cell Acute Lymphoblastic Leukemia: Emerging Data and Open Issues
Caterina Alati, Martina Pitea, Matteo Molica, et al.
Cancers
|
June 2, 2021
CART-Cell Therapy: Recent Advances and New Evidence in Multiple Myeloma
Massimo Martino, Filippo Antonio Canale, Caterina Alati, et al.
Cancer Medicine
|
September 18, 2015
Early lenalidomide treatment for low and intermediate-1 International Prognostic Scoring System risk myelodysplastic syndromes with del(5q) before transfusion dependence
Esther N Oliva, Michael Lauseker, Maria Antonietta Aloe Spiriti, et al.
Diseases (Basel, Switzerland)
|
December 24, 2025
Efficacy of Polyvinylpyrrolidone-Zinc Gluconate and Taurine Gel in the Prophylaxis of Oral Mucositis in Adults Undergoing High-Dose Chemotherapy and Allogeneic Stem Cell Transplantation
Gaetana Porto, Annalisa Pitino, Mercedes Gori, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
January 15, 2014
Long-term results in multiple myeloma after high-dose melphalan and autologous transplantation according to response categories in the era of old drugs
Massimo Martino, Maurizio Postorino, Giuseppe Alberto Gallo, et al.
Leukemia & Lymphoma
|
February 26, 2013
Lenalidomide in International Prognostic Scoring System Low and Intermediate-1 risk myelodysplastic syndromes with del(5q): an Italian phase II trial of health-related quality of life, safety and efficacy
Esther N Oliva, Roberto Latagliata, Carmelo Laganà, et al.
American Journal of Hematology
|
July 20, 2019
A bronchoalveolar lavage-driven antimicrobial treatment improves survival in hematologic malignancy patients with detected lung infiltrates: A prospective multicenter study of the SEIFEM group
Francesco Marchesi, Chiara Cattaneo, Marianna Criscuolo, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 43) with videos related to
Sort By:
Page
of 5
Cancers
|
November 13, 2025
SLAMF7: A Potential Target for CAR T-Cell Therapy in Multiple Myeloma
Caterina Alati, Martina Pitea, Gaetana Porto, et al.
Cancers
|
September 13, 2025
CD19 CAR-T Outcomes in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Retrospective Cohort Study from the Calabria Referral Center in Southern Italy
Daniele Caracciolo, Filippo Antonio Canale, Virginia Naso, et al.
Expert Review of Hematology
|
July 17, 2024
Optimizing maintenance therapy in acute myeloid leukemia: where do we stand in the year 2024?
Caterina Alati, Martina Pitea, Maria Caterina Mico, et al.
Cancers
|
September 27, 2025
CAR-T Cell Therapies in B-Cell Acute Lymphoblastic Leukemia: Emerging Data and Open Issues
Caterina Alati, Martina Pitea, Matteo Molica, et al.
Cancers
|
June 2, 2021
CART-Cell Therapy: Recent Advances and New Evidence in Multiple Myeloma
Massimo Martino, Filippo Antonio Canale, Caterina Alati, et al.
Cancer Medicine
|
September 18, 2015
Early lenalidomide treatment for low and intermediate-1 International Prognostic Scoring System risk myelodysplastic syndromes with del(5q) before transfusion dependence
Esther N Oliva, Michael Lauseker, Maria Antonietta Aloe Spiriti, et al.
Diseases (Basel, Switzerland)
|
December 24, 2025
Efficacy of Polyvinylpyrrolidone-Zinc Gluconate and Taurine Gel in the Prophylaxis of Oral Mucositis in Adults Undergoing High-Dose Chemotherapy and Allogeneic Stem Cell Transplantation
Gaetana Porto, Annalisa Pitino, Mercedes Gori, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
January 15, 2014
Long-term results in multiple myeloma after high-dose melphalan and autologous transplantation according to response categories in the era of old drugs
Massimo Martino, Maurizio Postorino, Giuseppe Alberto Gallo, et al.
Leukemia & Lymphoma
|
February 26, 2013
Lenalidomide in International Prognostic Scoring System Low and Intermediate-1 risk myelodysplastic syndromes with del(5q): an Italian phase II trial of health-related quality of life, safety and efficacy
Esther N Oliva, Roberto Latagliata, Carmelo Laganà, et al.
American Journal of Hematology
|
July 20, 2019
A bronchoalveolar lavage-driven antimicrobial treatment improves survival in hematologic malignancy patients with detected lung infiltrates: A prospective multicenter study of the SEIFEM group
Francesco Marchesi, Chiara Cattaneo, Marianna Criscuolo, et al.
Page
of 5